SWOG clinical trial number

CTSU/NHLBI-MDS

The National Myelodysplastic Syndromes (MDS) Study

Open

Phase

Abbreviated Title

NHLBI-MDS

Activated

06/01/2019

Research committees

Prevention & Epidemiology

Leukemia

Other Clinical Trials

SWOG Clinical Trial Number

CTSU/A042001

A Randomized Phase II Study Comparing Inotuzumab Plus Chemotherapy Versus Standard Chemotherapy in Older Adults with Philadelphia-Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia

Research Committee(s)

Leukemia

Activated

02/27/2023

Open

Phase

SWOG Clinical Trial Number

S1925

A Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia (CLL): EVOLVE CLL Study.

Research Committee(s)

Leukemia

Lymphoma

Symptom Control and Quality of Life

Activated

12/14/2020

Accrual

49%

Open

Phase

SWOG Clinical Trial Number

CTSU/AALL1821

A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination with Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old with First Relapse

Research Committee(s)

Leukemia

Activated

12/04/2020

Open